441 related articles for article (PubMed ID: 15099905)
1. Bioprocess development for the production of a recombinant MUC1 fusion protein expressed by CHO-K1 cells in protein-free medium.
Link T; Bäckström M; Graham R; Essers R; Zörner K; Gätgens J; Burchell J; Taylor-Papadimitriou J; Hansson GC; Noll T
J Biotechnol; 2004 May; 110(1):51-62. PubMed ID: 15099905
[TBL] [Abstract][Full Text] [Related]
2. Recombinant MUC1 mucin with a breast cancer-like O-glycosylation produced in large amounts in Chinese-hamster ovary cells.
Bäckström M; Link T; Olson FJ; Karlsson H; Graham R; Picco G; Burchell J; Taylor-Papadimitriou J; Noll T; Hansson GC
Biochem J; 2003 Dec; 376(Pt 3):677-86. PubMed ID: 12950230
[TBL] [Abstract][Full Text] [Related]
3. A novel control scheme for inducing angiostatin-human IgG fusion protein production using recombinant CHO cells in a oscillating bioreactor.
Wang IK; Hsieh SY; Chang KM; Wang YC; Chu A; Shaw SY; Ou JJ; Ho L
J Biotechnol; 2006 Feb; 121(3):418-28. PubMed ID: 16162365
[TBL] [Abstract][Full Text] [Related]
4. Process parameter shifting: Part II. Biphasic cultivation-A tool for enhancing the volumetric productivity of batch processes using Epo-Fc expressing CHO cells.
Trummer E; Fauland K; Seidinger S; Schriebl K; Lattenmayer C; Kunert R; Vorauer-Uhl K; Weik R; Borth N; Katinger H; Müller D
Biotechnol Bioeng; 2006 Aug; 94(6):1045-52. PubMed ID: 16736532
[TBL] [Abstract][Full Text] [Related]
5. Process parameter shifting: Part I. Effect of DOT, pH, and temperature on the performance of Epo-Fc expressing CHO cells cultivated in controlled batch bioreactors.
Trummer E; Fauland K; Seidinger S; Schriebl K; Lattenmayer C; Kunert R; Vorauer-Uhl K; Weik R; Borth N; Katinger H; Müller D
Biotechnol Bioeng; 2006 Aug; 94(6):1033-44. PubMed ID: 16736530
[TBL] [Abstract][Full Text] [Related]
6. Transmembrane and secreted MUC1 probes show trafficking-dependent changes in O-glycan core profiles.
Engelmann K; Kinlough CL; Müller S; Razawi H; Baldus SE; Hughey RP; Hanisch FG
Glycobiology; 2005 Nov; 15(11):1111-24. PubMed ID: 15972891
[TBL] [Abstract][Full Text] [Related]
7. Effects of elevated pCO2 and osmolality on growth of CHO cells and production of antibody-fusion protein B1: a case study.
Zhu MM; Goyal A; Rank DL; Gupta SK; Vanden Boom T; Lee SS
Biotechnol Prog; 2005; 21(1):70-7. PubMed ID: 15903242
[TBL] [Abstract][Full Text] [Related]
8. Stable production of a human growth hormone antagonist from CHO cells adapted to serum-free suspension culture.
Haldankar R; Kopchick JJ; Ridgway D
Biotechnol Prog; 1999; 15(3):336-46. PubMed ID: 10356250
[TBL] [Abstract][Full Text] [Related]
9. Comparison of a production process in a membrane-aerated stirred tank and up to 1000-L airlift bioreactors using BHK-21 cells and chemically defined protein-free medium.
Hesse F; Ebel M; Konisch N; Sterlinski R; Kessler W; Wagner R
Biotechnol Prog; 2003; 19(3):833-43. PubMed ID: 12790647
[TBL] [Abstract][Full Text] [Related]
10. Impact of dynamic online fed-batch strategies on metabolism, productivity and N-glycosylation quality in CHO cell cultures.
Chee Furng Wong D; Tin Kam Wong K; Tang Goh L; Kiat Heng C; Gek Sim Yap M
Biotechnol Bioeng; 2005 Jan; 89(2):164-77. PubMed ID: 15593097
[TBL] [Abstract][Full Text] [Related]
11. Flow cytometry-based assay to evaluate human serum MUC1-Tn antibodies.
Van Elssen CH; Clausen H; Germeraad WT; Bennet EP; Menheere PP; Bos GM; Vanderlocht J
J Immunol Methods; 2011 Feb; 365(1-2):87-94. PubMed ID: 21194532
[TBL] [Abstract][Full Text] [Related]
12. Scale-up analysis for a CHO cell culture process in large-scale bioreactors.
Xing Z; Kenty BM; Li ZJ; Lee SS
Biotechnol Bioeng; 2009 Jul; 103(4):733-46. PubMed ID: 19280669
[TBL] [Abstract][Full Text] [Related]
13. Serum-free production of recombinant proteins and adenoviral vectors by 293SF-3F6 cells.
Côté J; Garnier A; Massie B; Kamen A
Biotechnol Bioeng; 1998 Sep; 59(5):567-75. PubMed ID: 10099373
[TBL] [Abstract][Full Text] [Related]
14. Control of culture environment for improved polyethylenimine-mediated transient production of recombinant monoclonal antibodies by CHO cells.
Galbraith DJ; Tait AS; Racher AJ; Birch JR; James DC
Biotechnol Prog; 2006; 22(3):753-62. PubMed ID: 16739959
[TBL] [Abstract][Full Text] [Related]
15. Low-glutamine fed-batch cultures of 293-HEK serum-free suspension cells for adenovirus production.
Lee YY; Yap MG; Hu WS; Wong KT
Biotechnol Prog; 2003; 19(2):501-9. PubMed ID: 12675594
[TBL] [Abstract][Full Text] [Related]
16. Inclusion of S-sepharose beads in the culture medium significantly improves recovery of secreted rBPI(21) from transfected CHO-K1 cells.
Horwitz AH; Carroll SF; Williams RE; Liu PS
Protein Expr Purif; 2000 Feb; 18(1):77-85. PubMed ID: 10648172
[TBL] [Abstract][Full Text] [Related]
17. Process development for a recombinant Chinese hamster ovary (CHO) cell line utilizing a metal induced and amplified metallothionein expression system.
Huang EP; Marquis CP; Gray PP
Biotechnol Bioeng; 2004 Nov; 88(4):437-50. PubMed ID: 15459913
[TBL] [Abstract][Full Text] [Related]
18. Production of rhEPO with a serum-free medium in the packed bed bioreactor.
Deng J; Yang Q; Cheng X; Li L; Zhou J
Chin J Biotechnol; 1997; 13(4):247-52. PubMed ID: 9631260
[TBL] [Abstract][Full Text] [Related]
19. Improved bioprocess with CHO-hTSH cells on higher microcarrier concentration provides higher overall biomass and productivity for rhTSH.
Ventini DC; Damiani R; Sousa AP; de Oliveira JE; Peroni CN; Ribela MT; Bartolini P; Tonso A; Soares CR; Pereira CA
Appl Biochem Biotechnol; 2011 Jun; 164(4):401-9. PubMed ID: 21181451
[TBL] [Abstract][Full Text] [Related]
20. Temperature reduction in cultures of hGM-CSF-expressing CHO cells: effect on productivity and product quality.
Bollati-Fogolín M; Forno G; Nimtz M; Conradt HS; Etcheverrigaray M; Kratje R
Biotechnol Prog; 2005; 21(1):17-21. PubMed ID: 15903236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
